Economic evaluation in health care: The point of view of informed physicians

被引:14
作者
Fattore, G [1 ]
Torbica, A [1 ]
机构
[1] Bocconi Univ, CERGAS, SDA, I-20135 Milan, Italy
关键词
decision making; economic evaluation; health-care management; Italy;
D O I
10.1111/j.1524-4733.2006.00096.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: We investigated health professionals with a solid background in health-care management and economics to get their opinion and attitude on the use of economic evaluation at the policy, organizational, and professional levels of decision-making. Methods: A 12-item questionnaire was sent to 374 Italian health-care professionals who received training in economic evaluation of health-care programs in the last 10 years at the Bocconi School of Management, Milan, Italy. Results: The response rate was 46.8% (175 questionnaires). All respondents stated that the basics of economic evaluation analysis must be part of the overall knowledge of health-care professionals. The usefulness of economic evaluation for professional activities was rated 3.83 (scale 1-5). Respondents stated that economic evaluation is used more for managerial decisions than for clinical ones (mean 2.89 vs. 2.74, P = 0.09). "Decisions are taken according to a short-term perspective" was the most frequently reported barrier for the actual use of economic evaluation studies, particularly by managers (76.7%). "More training in health economics" was indicated as the incentive to expand its use by the majority of both clinicians and managers (64.6%). Significantly more managers than clinicians (74.4% vs. 54.1%, P = 0.005) considered that the maximum benefits of economic evaluation are reaped at organizational level. Conclusions: Informed Italian health professionals have a positive attitude toward the principles and the techniques of economic evaluation. They show appreciation of their potential role and report making some use of them in actual decision making.
引用
收藏
页码:157 / 167
页数:11
相关论文
共 14 条
[1]   Pharmacoeconomics and clinical practice guidelines - A survey of attitudes in Swedish formulary committees [J].
Anell, A ;
Svarvar, P .
PHARMACOECONOMICS, 2000, 17 (02) :175-185
[2]  
CORNAGO D, 2005, EC POLITICA FARMACO, V4, P29
[3]   Economic evaluation under managed competition: Evidence from the UK [J].
Drummond, M ;
Cooke, J ;
Walley, T .
SOCIAL SCIENCE & MEDICINE, 1997, 45 (04) :583-595
[4]   Use of pharmacoeconomics information - Report of the ISPOR Task Force on use of pharmacoeconomic/health economic information in health-care decision making [J].
Drummond, M ;
Brown, R ;
Fendrick, AM ;
Fullerton, P ;
Neumann, P ;
Taylor, R ;
Barbieri, M .
VALUE IN HEALTH, 2003, 6 (04) :407-416
[5]   Research into the use of health economics in decision making in the United Kingdom - Phase II - Is health economics 'for good or evil?' [J].
Duthie, T ;
Trueman, P ;
Chancellor, J ;
Diez, L .
HEALTH POLICY, 1999, 46 (02) :143-157
[6]   A PRESCRIPTIVE CONTINGENCY VIEW OF ORGANIZATIONAL DECISION-MAKING [J].
GRANDORI, A .
ADMINISTRATIVE SCIENCE QUARTERLY, 1984, 29 (02) :192-209
[7]   The influence of economic evaluation studies on decision making. A European survey [J].
Hoffmann, C ;
von der Schulenburg, JMG .
HEALTH POLICY, 2000, 52 (03) :179-192
[8]   Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities [J].
Hoffmann, C ;
Stoykova, BA ;
Nixon, J ;
Glanville, JM ;
Misso, K ;
Drummond, MF .
VALUE IN HEALTH, 2002, 5 (02) :71-78
[9]  
MAIWENN JA, 2004, HLTH POLICY, V70, P33
[10]  
NEUMANN P, 1995, USING COST EFFECTIVE